Surgical Gloves Market Size & Growth Forecast 2027–2036, By Segments (Sterility, Form, Distribution, Usage, Material, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Surgical Gloves Market size was assessed at USD 2.3 billion in 2026 and is poised to grow at a 6.94% CAGR between 2027 and 2036, surpassing USD 4.5 billion by 2036. The industry revenue for 2027 is calculated at USD 2.43 billion.

• Base Year Value (2026): USD 2.3 billion
• CAGR (2027-2036): 6.94%
• Forecast Year Value (2036): USD 4.5 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Surgical Gloves Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America’s share is supported by high procedural volumes, strict infection control standards, mature hospital procurement systems, and consistent replacement demand across healthcare networks and surgical settings.
  • Asia Pacific growth is driven by rising healthcare utilization, expanding hospital infrastructure, increasing surgical procedures, and broader adoption of infection prevention protocols across clinical facilities.

• Segment Momentum:

  • Sterile gloves held 65.38% of the market in 2026 because they are routinely required in surgical and invasive procedures where infection control standards make sterility an essential purchasing criterion.
  • Powder gloves are the fastest-growing form segment as healthcare users value easier donning and handling efficiency in high-volume clinical environments where quick usability supports workflow needs.

• Market Expansion Drivers:

  • Increasing surgical procedures and infection control standards driving glove consumption.
  • Rising prevalence of chronic diseases expanding hospital and emergency care usage.
  • Material innovation such as nitrile adoption improving durability and allergen safety.

• Leading Market Participants:

  Leading companies in the surgical gloves market include Top Glove Corporation Bhd. (Malaysia), Hartalega Holdings Berhad (Malaysia), Ansell Limited (Australia), Cardinal Health, Inc. (United States), Medline Industries, LP (United States), Semperit AG Holding (Austria), Kanam Latex Industries Pvt. Ltd. (India), Narang Medical Limited (India), Globus Group (United Kingdom), Sun Healthcare (M) Sdn. Bhd. (Malaysia).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 2.3 billion
  • 2027 Estimated Market Size: USD 2.43 billion.
  • Projected Market Size: USD 4.5 billion by 2036
  • Growth Forecasts: 6.94% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Sterile Gloves (Sterility) | Powder-free (Form) | Offline (Distribution) | Disposable (Usage) | Natural Rubber (Material) | Hospital (End-use)
  • Emerging Opportunity Segment: Non- Sterile Gloves (Sterility) | Powder (Form) | Online (Distribution) | Disposable (Usage) | Nitrile (Material) | Emergency Medical Service (End-use)

Market Growth Drivers and Industry Trends

Increasing surgical procedures and infection control standards driving glove consumption

Growing surgical activity across hospitals, outpatient facilities, and specialized care centers is increasing the need for reliable protective barriers during invasive procedures. The surgical gloves market will benefit from stricter infection prevention practices that require healthcare workers to use appropriate protective gloves during surgery and other sterile interventions. Greater emphasis on aseptic techniques, hand hygiene, and prevention of healthcare-associated infections is also encouraging facilities to maintain consistent glove availability across operating rooms and procedure areas.

Rising prevalence of chronic diseases expanding hospital and emergency care usage

The increasing burden of chronic conditions is contributing to sustained utilization of healthcare services, including surgical interventions, diagnostic procedures, emergency treatment, and long-term clinical care. As hospital and emergency care activity expands, the surgical gloves market gains support from the corresponding need for protective equipment across procedures where sterile or examination-grade barriers are required. Conditions that lead to operative treatment or repeated clinical interventions can generate recurring demand for gloves among surgical teams, nursing personnel, and other healthcare professionals.

Material innovation such as nitrile adoption improving durability and allergen safety

Advances in glove materials are enabling healthcare providers to select products that combine protection, tactile performance, flexibility, and resistance to tearing during demanding procedures. Nitrile adoption will propel the surgical gloves market by providing an alternative to natural rubber latex for facilities seeking durable barrier protection while reducing concerns associated with latex-related sensitivities. Improvements in material formulation and glove design are also supporting better fit, dexterity, puncture resistance, and comfort during prolonged surgical use.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing surgical procedures and infection control standards driving glove consumption	2.10%	High	North America, Europe, Asia Pacific	High	Near Term
Rising prevalence of chronic diseases expanding hospital and emergency care usage	1.80%	High	Global	High	Near Term
Material innovation such as nitrile adoption improving durability and allergen safety	1.60%	Moderate	North America, Asia Pacific	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

The surgical gloves market was led by North America, which held a share of 38.80% in 2026, reflecting strong healthcare infrastructure, high surgical activity, and rigorous standards for infection prevention and medical safety. Hospitals and healthcare facilities maintain substantial demand for high-quality surgical gloves as part of infection-control protocols, while stringent regulatory requirements support consistent adoption of products that meet established safety and performance standards. Growing emphasis on healthcare worker protection and patient safety is also encouraging the use of specialized glove materials and improved barrier technologies. In addition, well-developed procurement systems and continued investment in healthcare facilities contribute to stable regional demand and reinforce North America's leading position.

Asia Pacific is experiencing the fastest growth in the surgical gloves market, supported by expanding healthcare infrastructure, increasing access to surgical care, and rising awareness of infection prevention. The development of hospitals and specialized medical facilities across emerging economies is broadening the need for essential surgical consumables, while improvements in healthcare standards are encouraging greater compliance with protective equipment requirements. Rising healthcare expenditure and the expansion of surgical services are further supporting consumption. Increasing attention to hospital-acquired infection prevention and improvements in domestic medical supply capabilities are also strengthening regional demand, positioning Asia Pacific as an important growth center for the surgical gloves industry.

Key Country Insights

United States

Healthcare Procurement Focus

The U.S. surgical gloves market prioritizes dependable supply continuity, product quality, and compliance with evolving infection prevention standards. U.S. healthcare providers increasingly evaluate suppliers based on consistent performance, material innovation, and dependable distribution capabilities across hospital networks.

Japan

Premium Safety Preference

Japan prioritizes surgical gloves designed for precision, user comfort, and dependable protection during complex medical procedures. Japanese hospitals increasingly adopt premium glove solutions that improve tactile sensitivity while supporting stringent infection control requirements.

South Korea

Advanced Product Adoption

South Korea supports surgical glove demand through modern healthcare infrastructure and increasing preference for technologically enhanced medical consumables. South Korean healthcare facilities seek products combining durability, comfort, and consistent quality to improve procedural efficiency and patient safety.

Germany

Clinical Quality Standards

Germany emphasizes surgical gloves that meet demanding clinical performance requirements and strict regulatory expectations. German healthcare institutions increasingly prefer products offering reliable barrier protection, ergonomic comfort, and sustainable manufacturing practices within procurement decisions.

France

Sustainable Procurement Approach

France increasingly incorporates sustainability considerations alongside product performance in surgical glove procurement. French healthcare providers evaluate suppliers capable of delivering certified quality, reliable supply, and environmentally responsible manufacturing without compromising clinical safety standards.

Italy

Hospital Supply Reliability

Italy focuses on maintaining reliable surgical glove availability across public and private healthcare facilities while meeting regulatory requirements. Italian procurement organizations value suppliers offering dependable logistics, product consistency, and a broad portfolio suited to diverse surgical applications.

Segment Leadership and Growth Trends

 

Sterility Segment Analysis: Sterile Gloves (Largest Segment) vs Non- Sterile Gloves (Fastest-Growing Segment)

The sterile gloves segment dominated the surgical gloves market in 2026, accounting for a 65.38% share. Sterile gloves are essential for surgical procedures where maintaining a controlled environment and minimizing contamination risks are critical. Their widespread use across operating rooms, invasive procedures, and other settings requiring strict infection-control practices supports their strong market position. Increasing emphasis on healthcare-associated infection prevention and adherence to rigorous surgical protocols further reinforces demand for sterile protective barriers. The continued expansion of surgical care and greater attention to clinical safety also contribute to sustained utilization across healthcare facilities.

Non-sterile gloves represent the fastest-growing sterility segment, supported by their broad use in healthcare activities where sterility is not required but hand protection and contamination control remain important. They are suitable for routine examinations, patient handling, diagnostic activities, and various non-invasive procedures. Their practicality and cost-effectiveness make them valuable across a wide range of healthcare environments beyond operating rooms. Growing attention to general infection prevention and increased use of protective gloves in routine clinical workflows are strengthening demand for non-sterile products.

Form Segment Analysis: Powder-free (Largest Segment) vs Powder (Fastest-Growing Segment)

Powder-free gloves held the largest position in the surgical gloves market in 2026, representing an 82.94% share. Their dominance is supported by growing awareness of the potential complications associated with glove powder, including irritation, contamination concerns, and interference with wound healing or clinical procedures. Powder-free products provide a cleaner option for surgical environments and are increasingly aligned with infection-control and patient-safety priorities. Their suitability for sensitive clinical applications and compatibility with modern healthcare protocols have made them the preferred form across many medical settings.

Powder gloves constitute the fastest-growing form segment as demand remains supported by applications where ease of donning and handling can be advantageous. Powder can reduce friction when gloves are being put on, which may improve convenience during certain routine tasks. Continued demand from healthcare environments that prioritize operational efficiency and frequent glove changes supports this segment. However, its use remains more application-specific as healthcare providers increasingly emphasize alternatives that address contamination and sensitivity concerns.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Sterility	Sterile Gloves, Non- Sterile Gloves	Sterile Gloves	Non- Sterile Gloves
Form	Powder, Powder-free	Powder-free	Powder
Distribution	Online, Offline	Offline	Online
Usage	Disposable, Reusable	Disposable	Disposable
Material	Natural Rubber, Nitrile, Neoprene, Polyisoprene, Others	Natural Rubber	Nitrile
End-use	Hospital, Veterinary, Emergency Medical Service, Dental, Others	Hospital	Emergency Medical Service

Competitive Landscape and Market Positioning

Major players in the surgical gloves market:

1. Top Glove Corporation Bhd. (Malaysia)

2. Hartalega Holdings Berhad (Malaysia)

3. Ansell Limited (Australia)

4. Cardinal Health Inc. (United States)

5. Medline Industries LP (United States)

6. Semperit AG Holding (Austria)

7. Kanam Latex Industries Pvt. Ltd. (India)

8. Narang Medical Limited (India)

9. Globus Group (United Kingdom)

10. Sun Healthcare (M) Sdn. Bhd. (Malaysia)

The surgical gloves market is evolving through increased focus on enhanced barrier protection, material durability, and manufacturing efficiency to meet stringent healthcare standards. Manufacturers are introducing advanced glove formulations designed to improve tactile sensitivity, comfort, and infection control performance in surgical environments. Automation investments and quality assurance advancements are also contributing to stronger competitiveness across the surgical gloves market.

Industry Development/News

Company Name	Date	Key Development
Mölnlycke	Sep-22	Mölnlycke inaugurated a new surgical glove manufacturing facility in Kulim Hi-Tech Park, Malaysia. Designed with sustainable production at its core, the plant increases the company's global output capacity, enabling it to scale its footprint in the surgical glove segment and better support the supply requirements of its international customer base.
Cardinal Health	Sep-22	Cardinal Health expanded its surgical glove manufacturing operations in Rayong, Thailand, by establishing a second advanced facility. This expansion added over 1.3 million square feet of production space, significantly increasing the company's capacity to manufacture high-volume surgical products and strengthening its competitive position in the global healthcare supply chain.
USMGC	Aug-24	USMGC acquired a polyisoprene chemical production facility and established an independent division to manage raw nitrile and polyisoprene output. This strategic vertical integration provides the company with direct control over essential feedstock, enhancing its upstream supply chain resilience for high-performance surgical glove materials.
DL Chemical	Nov-24	DL Chemical commenced operations at its new Cariflex polyisoprene latex plant in Singapore. As the world’s largest facility of its kind, this expansion significantly boosts global production capacity for high-purity polyisoprene latex—a critical raw material for surgical gloves—thereby increasing supply stability for premium medical-grade elastomeric components.
USMGC	May-25	USMGC secured a 638,000 square-foot manufacturing facility in Ohio to finalize its domestic supply chain initiative. By producing machinery, chemicals, and finished nitrile and polyisoprene gloves within the U.S., the company aims to eliminate dependence on foreign material sources and establish a fully localized, secure manufacturing ecosystem for medical and surgical gloves.
Ansell	May-25	Ansell secured a national group purchasing agreement with Premier, Inc. for its surgical gloves category. This contract grants Premier members access to pre-negotiated, exclusive pricing and terms across Ansell’s portfolio, strengthening the company's distribution reach and competitive positioning within the U.S. hospital and healthcare provider networks.
Enliva	May-25	Enliva launched a new range of accelerator-free nitrile gloves designed to improve skin safety for healthcare professionals. By removing common chemical accelerators that frequently cause dermatitis or allergies, the product addresses specific clinical needs for long-duration protection, reinforcing the company's market presence in the specialty-glove segment.
ZAS Corporation	Sep-25	ZAS Corporation launched the DECA series of sterile surgical gloves, focusing on advanced durability and tactile sensitivity. This addition to the company's medical portfolio aims to meet the demand for high-performance protective gear in surgical environments, allowing the company to compete in the premium-tier surgical glove market.